A Phase-II, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Cardiovascular Events in Patients With Prostate Cancer and Cardiovascular Risk Factors Receiving Degarelix or GnRH Agonist
Latest Information Update: 20 Jan 2023
At a glance
- Drugs Degarelix (Primary) ; LHRH receptor agonists
- Indications Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Dec 2019 New trial record